Clinical trial
Islet Transplantation Using Campath-1H and Infliximab Induction
NCT00175266 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00175266 |
|---|---|
| Title | Islet Transplantation Using Campath-1H and Infliximab Induction |
| Official title | Islet Transplantation in Type 1 Diabetic Patients Using Campath-1H and Infliximab Induction |
| Lead sponsor | University of Alberta, Other |
| Collaborators | Juvenile Diabetes Research Foundation |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Type 1 Diabetes |
| Intervention type | Drug, Procedure |
| Interventions | alemtuzumab, islet transplant, infliximab |
| Enrollment | 12 |
| First posted | Sep 15, 2005 |
| Last update posted | Oct 2, 2009 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: